IFNA2 Protein
-
- Target See all IFNA2 Proteins
- IFNA2 (Interferon, alpha 2 (IFNA2))
- Protein Type
- Recombinant
-
Origin
- Human
-
Source
- Escherichia coli (E. coli)
- Application
- SDS-PAGE (SDS)
- Supplier Product No.
- 009-001-v19-0020
- Supplier
- Rockland
- Purpose
- Human Interferon-alpha 2b Recombinant Protein
- Purification
- Interferon-alpha 2b purity was determined to be greater than 98% as determined by HpLC and by reducing and non-reducing SDS-pAGE.
- Purity
- 98,00%
- Endotoxin Level
- Measured by LAL is typically ≤ 1 EU/μg protein.
- Biological Activity Comment
- The activity is determined by the ability induce antiviral activity.
- Top Product
- Discover our top product IFNA2 Protein
-
-
- Application Notes
-
Other: User Optimized
Application_Note: Interferon-alpha 2b Recombinant Protein has been tested by SDS-PAGE and is suitable as a control for polyclonal or monoclonal anti-Interferon-alpha 2b in immunological assays.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
-
Reconstitution_Buffer: Restore with deionized water (or equivalent)
Reconstitution_Volume: 20 μL (20-200 μL)
- Buffer
-
Buffer: None
Stabilizer: None
- Preservative
- Without preservative
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store vial at 4° C prior to restoration. Dilute only prior to immediate use. Maintain sterility. This product DOES NOT contain preservative. DO NOT VORTEX. We recommend adding a carrier protein such as HSA or BSA to 0.1% (i.e. 1.0 mg/mL). For best results aliquot contents and freeze at -20° C or colder. Avoid cycles of freezing and thawing. Centrifuge vial before each opening to dislodge contents from the cap and to clarify if contents are not clear after standing at room temperature.
- Expiry Date
- 6 months
-
- Target
- IFNA2 (Interferon, alpha 2 (IFNA2))
- Alternative Name
- IFNA2 (IFNA2 Products)
- Background
-
Synonyms: Interferon alpha-A (LeIF A)Type I Interferon, Alpha 2
Background: Interferon-alpha 2b (IFNα 2b) is a Type I interferon made by leukocytes during viral infection. It has anti-viral and non-proliferative activity induced by JAK1-STAT signaling. IFN-alphas are the most widely used type for therapeutic purposes. IFNα 2b is a variant of IFNα 2a that differs by one amino acid. Recombinant human IFNα 2b is a non-glycosylated protein, containing 166 amino acids, with a molecular weight of 19.4 kDa.
- UniProt
- P01563
- Pathways
- JAK-STAT Signaling, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
-